Resultado final
At least 500 mg of reactive ncAA AhA will be produced by biotechnological means
Bioproduction of unmodified spidroinsAt least 500 mg of unmodified spidroins will be biologically produced
Production of activated affinity ligandsAt least 250 mg of each activated affinity ligand will be attained The affinity ligands selective for factor VIII Mabs VLPs and protein A will be produced and modified with DBCO for further modification of labeled spidroin
Data Management PlanA detailed Data Management Plan will be created at the beginning of the project to ensure that all data is findable accessible interoperable and reusable FAIR The plan will be harmonized with a knowledge protection plan IPR plan
Dissemination and Exploitation Plan at the end of the first Reporting Period RP1 M12
Publicaciones
Autores:
Charlotte Leonhardt
Publicado en:
2021
Editor:
Universitat Bayreuth
Autores:
Amelie Linder
Publicado en:
2022
Editor:
Universitat Bayreuth
Autores:
José Pedro Fradique Lourenço Dias Dinis
Publicado en:
2022
Editor:
Universidade NOVA de Lisboa
Autores:
Costa, Carlos Filipe Santos; Barbosa, Arménio J. M.; Dias, Ana Margarida Gonçalves Carvalho; Roque, Ana Cecília A.
Publicado en:
Biotechnology Advances, Edición 59, 2022, Página(s) 107986, ISSN 0734-9750
Editor:
Elsevier BV
DOI:
10.1016/j.biotechadv.2022.107986
Buscando datos de OpenAIRE...
Se ha producido un error en la búsqueda de datos de OpenAIRE
No hay resultados disponibles